SCC-researchers are mapping genetic changes - leads to targeted cancer treatment
In collaboration with colleagues at Memorial Sloan Kettering Cancer Center in New York, researchers at Sahlgrenska Cancer Center have identified new fusion oncogenes which drives the development of a serious form of Salivary gland tumours. The research results are being published in the scientific journal Nature Communications and is a direct effect of the faculty's effort on Sahlgrenska Academy Seminars.
Area
Health and
medicine